GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 81 filers reported holding GALECTIN THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $35,000 | -2.8% | 16,006 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $36,000 | -16.3% | 16,006 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $43,000 | -14.0% | 16,006 | -2.8% | 0.00% | 0.0% |
| Q2 2020 | $50,000 | +56.2% | 16,461 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $32,000 | -31.9% | 16,461 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $47,000 | -21.7% | 16,461 | 0.0% | 0.00% | -50.0% |
| Q3 2019 | $60,000 | -24.1% | 16,461 | -13.5% | 0.00% | 0.0% |
| Q2 2019 | $79,000 | -17.7% | 19,021 | 0.0% | 0.00% | -33.3% |
| Q1 2019 | $96,000 | +45.5% | 19,021 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $66,000 | -67.5% | 19,021 | -43.6% | 0.00% | -57.1% |
| Q3 2018 | $203,000 | -5.6% | 33,721 | 0.0% | 0.01% | -36.4% |
| Q2 2018 | $215,000 | +305.7% | 33,721 | +114.5% | 0.01% | +450.0% |
| Q4 2017 | $53,000 | +55.9% | 15,721 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $34,000 | -10.5% | 15,721 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $38,000 | – | 15,721 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cutter & CO Brokerage, Inc. | 169,578 | $222,000 | 0.08% |
| Geneos Wealth Management Inc. | 478,067 | $626,000 | 0.03% |
| SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $16,000 | 0.01% |
| Atria Wealth Solutions, Inc. | 281,700 | $369,000 | 0.01% |
| Vivaldi Capital Management LP | 17,078 | $22,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 1,284,481 | $1,684,000 | 0.00% |
| Ameritas Advisory Services, LLC | 45,302 | $59,000 | 0.00% |
| CENTAURUS FINANCIAL, INC. | 20,947 | $27,000 | 0.00% |
| Summit Trail Advisors, LLC | 23,855 | $31,000 | 0.00% |
| WEDBUSH SECURITIES INC | 27,998 | $37,000 | 0.00% |